Hanne Capital, founded in early 2017, is a healthcare venture capital fund focusing on early and growth-stage investments in the Greater China healthcare industry. The founding partners have extensive experience in private equity and multinational pharmaceutical companies, with a track record of significant milestones. The firm has invested over $500 million in various healthcare companies and has several successful IPOs in mainland China, the US, Hong Kong, and Taiwan, with a total market capitalization exceeding $10 billion.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions